{"web_snippets": ["Larimar Therapeutics Inc. \u00b7 Industry Pharmaceuticals \u00b7 Sector Health Care/Life Sciences \u00b7 Fiscal Year-end 12/2024 \u00b7 Revenue N/A \u00b7 Net Income -\u20ac36.95M \u00b7 2023 Sales ...", "Gosebruch named CEO of Neumora. Plus: Petti becomes CEO at Leucid Bio, and updates from Acelyrin, Larimar, Pharming and more. Read More. BioCentury | Feb 7 ...", "Larimar Therapeutics is a clinical-stage biopharmaceutical company that ... N/A, N/A. Investment Income, N/A, N/A. Larimar Therapeutics, Inc. Business ..."], "demographic_clues": ["female_indicator", "male_indicator"], "search_performed": true}